ENTITY
Sun Pharmaceutical Industries

Sun Pharmaceutical Industries (SUNP IN)

143
Analysis
Health CareIndia
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
more
Refresh
12 Jan 2018 09:51

BBSP Equity Asia Weekly Research 10th January 2018

Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAP• HSCEI/MXAP ratio is moving in a range pattern. Therefore downgrade...

Logo
BBSP Asia
320 Views
Share
28 Dec 2017 23:24

Emerging Markets: Outlook and Recommendations

Today's report provides a synopsis of the technical state of emerging markets, along with actionable countries and a wide variety of bottom-up...

Logo
169 Views
Share
30 Nov 2017 02:29

Emerging Markets: Technical Strategy & Reccommendations

Today’s report provides a top-down synopsis of the technical condition of emerging markets across the globe, and includes a wide variety of...

Logo
968 Views
Share
bearishLarsen & Toubro
12 Sep 2017 17:12

India: After Maruti Suzuki and Reliance Industries, Will Larsen & Toubro Outperform the Markets Now?

It has been a struggle to find money making ideas in Indian large cap spaceIndian markets have done well in CY17 with BSE SENSEX delivering...

Logo
184 Views
Share
bearishDaiichi Sankyo
10 Jul 2017 05:54

Daiichi Sankyo (4568) - Is Luck Running Out?

Daiichi Sankyo (4568 JP) has been seen as leading something of a charmed life in recent months, most notably when Sun Pharmaceutical (SUNP IN) paid...

x